| Mycolic acids: structure, biosynthesis and physiological functions CE Barry Iii, RE Lee, K Mdluli, AE Sampson, BG Schroeder, RA Slayden, ... Progress in lipid research 37 (2-3), 143-179, 1998 | 759 | 1998 |
| Inhibition of a Mycobacterium tuberculosis β-Ketoacyl ACP Synthase by Isoniazid K Mdluli, RA Slayden, YQ Zhu, S Ramaswamy, X Pan, D Mead, DD Crane, ... Science 280 (5369), 1607-1610, 1998 | 609 | 1998 |
| Biogenesis of the mycobacterial cell wall and the site of action of ethambutol K Mikusova, RA Slayden, GS Besra, PJ Brennan Antimicrobial agents and chemotherapy 39 (11), 2484-2489, 1995 | 425 | 1995 |
| The genetics and biochemistry of isoniazid resistance in Mycobacterium tuberculosis RA Slayden, CE Barry III Microbes and Infection 2 (6), 659-669, 2000 | 317 | 2000 |
| High affinity InhA inhibitors with activity against drug-resistant strains of Mycobacterium tuberculosis TJ Sullivan, JJ Truglio, ME Boyne, P Novichenok, X Zhang, CF Stratton, ... ACS chemical biology 1 (1), 43-53, 2006 | 307 | 2006 |
| Combinatorial lead optimization of [1, 2]-diamines based on ethambutol as potential antituberculosis preclinical candidates RE Lee, M Protopopova, E Crooks, RA Slayden, M Terrot, CE Barry Journal of combinatorial chemistry 5 (2), 172-187, 2003 | 296 | 2003 |
| Hypoxic Response of Mycobacterium tuberculosis Studied by Metabolic Labeling and Proteome Analysis of Cellular and Extracellular Proteins I Rosenkrands, RA Slayden, J Crawford, C Aagaard, CE Barry III, ... Journal of bacteriology 184 (13), 3485-3491, 2002 | 252 | 2002 |
| Isoniazid affects multiple components of the type II fatty acid synthase system of Mycobacterium tuberculosis RA Slayden, RE Lee, CE Barry 3rd Molecular microbiology 38 (3), 514-525, 2000 | 209 | 2000 |
| Unique mechanism of action of the thiourea drug isoxyl on Mycobacterium tuberculosis B Phetsuksiri, M Jackson, H Scherman, M McNeil, GS Besra, AR Baulard, ... Journal of Biological Chemistry 278 (52), 53123-53130, 2003 | 204 | 2003 |
| Use of genomics and combinatorial chemistry in the development of new antimycobacterial drugs CE Barry III, RA Slayden, AE Sampson, RE Lee Biochemical pharmacology 59 (3), 221-231, 2000 | 202 | 2000 |
| Antimycobacterial action of thiolactomycin: an inhibitor of fatty acid and mycolic acid synthesis RA Slayden, RE Lee, JW Armour, AM Cooper, IM Orme, PJ Brennan, ... Antimicrobial agents and chemotherapy 40 (12), 2813-2819, 1996 | 199 | 1996 |
| Novel Trisubstituted Benzimidazoles, Targeting Mtb FtsZ, as a New Class of Antitubercular Agents K Kumar, D Awasthi, SY Lee, I Zanardi, B Ruzsicska, S Knudson, ... Journal of medicinal chemistry 54 (1), 374-381, 2011 | 198 | 2011 |
| Menaquinone synthesis is critical for maintaining mycobacterial viability during exponential growth and recovery from non‐replicating persistence RK Dhiman, S Mahapatra, RA Slayden, ME Boyne, A Lenaerts, ... Molecular microbiology 72 (1), 85-97, 2009 | 164 | 2009 |
| Disease State Differentiation and Identification of Tuberculosis Biomarkers via Native Antigen Array Profiling* S MJ Sartain, RA Slayden, KK Singh, S Laal, JT Belisle Molecular & cellular proteomics 5 (11), 2102-2113, 2006 | 143 | 2006 |
| Targeting FtsZ for antituberculosis drug discovery: noncytotoxic taxanes as novel antituberculosis agents Q Huang, F Kirikae, T Kirikae, A Pepe, A Amin, L Respicio, RA Slayden, ... Journal of medicinal chemistry 49 (2), 463-466, 2006 | 138 | 2006 |
| Identification of cell cycle regulators in Mycobacterium tuberculosis by inhibition of septum formation and global transcriptional analysis RA Slayden, DL Knudson, JT Belisle Microbiology 152 (6), 1789-1797, 2006 | 130 | 2006 |
| Slow-Onset Inhibition of the FabI Enoyl Reductase from Francisella tularensis: Residence Time and in Vivo Activity H Lu, K England, C am Ende, JJ Truglio, S Luckner, BG Reddy, ... ACS chemical biology 4 (3), 221-231, 2009 | 129 | 2009 |
| Synthesis and SAR studies of 1, 4-benzoxazine MenB inhibitors: Novel antibacterial agents against Mycobacterium tuberculosis X Li, N Liu, H Zhang, SE Knudson, RA Slayden, PJ Tonge Bioorganic & medicinal chemistry letters 20 (21), 6306-6309, 2010 | 124 | 2010 |
| A Point Mutation in the mma3 Gene Is Responsible for Impaired Methoxymycolic Acid Production in Mycobacterium bovis BCG Strains Obtained after 1927 MA Behr, BG Schroeder, JN Brinkman, RA Slayden, CE Barry III Journal of bacteriology 182 (12), 3394-3399, 2000 | 122 | 2000 |
| Identification of the apparent carrier in mycolic acid synthesis. GS Besra, T Sievert, RE Lee, RA Slayden, PJ Brennan, K Takayama Proceedings of the National Academy of Sciences 91 (26), 12735-12739, 1994 | 114 | 1994 |
